Home / Lanreotide / Austria
AT ATC H01CB03 · updated 2 Nov 2026
Lanreotide shortage in Austria
Is there a Lanreotide shortage in Austria?
Yes. As of 2 Nov 2026, 3 Lanreotide products are reported short in Austria, the first since 1 Aug 2024. The company estimate for the return is 2 Feb 2027. Main reason: distribution or logistics.
Also short in Germany, Italy, Spain, Norway, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Mytolac 120 mg Injektionslösung in einer Fertigspritze, 1 Stück | Amdipharm Limited | 1 Aug 2024 | 2 Feb 2027 | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Mytolac 60 mg Injektionslösung in einer Fertigspritze, 1 Stück | Amdipharm Limited | 1 Aug 2024 | 2 Feb 2027 | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Mytolac 90 mg Injektionslösung in einer Fertigspritze, 1 Stück | Amdipharm Limited | 1 Aug 2024 | 2 Feb 2027 | Distribution or logistics Verzögerung bei der Auslieferung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).